Physician profile
Christopher Michael Annis
NPI 1376760827
$4,156.88
in general payments reported to CMS, 2019-2025
11 companies · $1,518 in 2025
The $1,518 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $454 · 2020: $263 · 2021: $110 · 2022: $787 · 2023: $239 · 2024: $786 · 2025: $1,518.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,544.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,543.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,336.64 | 2021-2025 | Intellis Adaptivestim, Accurian, Inceptiv |
| Abbott Laboratories | $564.67 | 2019-2024 | Proclaim |
| Globus Medical, INC. | $479.28 | 2025 | Senza |
| Nevro Corp. | $257.77 | 2019-2024 | Senza |
| Inspire Medical Systems, INC. | $163.80 | 2025 | Inspire |
| Portola Pharmaceuticals, LLC | $137.50 | 2019 | |
| Pacira Therapeutics, INC. | $105.83 | 2019 | |
| Stryker Corporation | $67.27 | 2022 | |
| Boston Scientific Corporation | $15.25 | 2019 | |
| Vertos Medical, INC. | $14.49 | 2022 | |
| Medtronic USA, INC. | $14.38 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Annis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.